Literature DB >> 2466764

Monoclonal antibodies to pertussis toxin: utilization as probes of toxin function.

J G Kenimer1, K J Kim, P G Probst, C R Manclark, D G Burstyn, J L Cowell.   

Abstract

Six monoclonal antibodies (MAbs) to pertussis toxin (PT) have been generated and characterized. Five of these MAbs (3CX4, 3C4D, 6D11C, 6FX1, and X2X5) interact with determinants on the catalytic subunit (S1) of PT, and one (6DX3) is specific for subunit S4. The MAbs are divided into three groups based upon their ability to neutralize the effects of PT in a Chinese hamster ovary (CHO) cell assay. Three of the MAbs (3CX4, 3C4D and 6D11C) had high neutralization titers, one MAb (6FX1) displayed weak neutralizing activity, and two MAbs (X2X5 and 6DX3) had no neutralizing ability. The combination of one of the high titer MAbs (3CX4) with the low titer MAb (6FX1) resulted in a synergistic enhancement of neutralizing capability. F(ab')2 fragments prepared from MAb's 3CX4 and X2X5 displayed activities in the CHO-cell assay which were identical to the native MAb's. The ability of the MAbs to neutralize PT in the CHO-cell toxin neutralization assay correlated with their ability to inhibit the in vitro ADP-ribosylation of PT. A competition ELISA method demonstrated that this panel of MAbs recognizes at least four separate epitopes on the PT molecule. Biotin-conjugated MAbs were shown to be useful reagents to probe the interaction of pertussis toxin with fetuin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2466764     DOI: 10.1089/hyb.1989.8.37

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  28 in total

1.  Importance of holotoxin assembly in Ptl-mediated secretion of pertussis toxin from Bordetella pertussis.

Authors:  K M Farizo; T Huang; D L Burns
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  Use of pertussis toxin encoded by ptx genes from Bordetella bronchiseptica to model the effects of antigenic drift of pertussis toxin on antibody neutralization.

Authors:  S Z Hausman; D L Burns
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

3.  DsbA and DsbC are required for secretion of pertussis toxin by Bordetella pertussis.

Authors:  Trevor H Stenson; Alison A Weiss
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

4.  Membrane localization of the S1 subunit of pertussis toxin in Bordetella pertussis and implications for pertussis toxin secretion.

Authors:  Karen M Farizo; Stefanie Fiddner; Anissa M Cheung; Drusilla L Burns
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

5.  Temporal expression of pertussis toxin and Ptl secretion proteins by Bordetella pertussis.

Authors:  Amy A Rambow-Larsen; Alison A Weiss
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

6.  Analysis of subassemblies of pertussis toxin subunits in vivo and their interaction with the ptl transport apparatus.

Authors:  Drusilla L Burns; Stefanie Fiddner; Anissa M Cheung; Anita Verma
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

7.  Analysis of relative levels of production of pertussis toxin subunits and Ptl proteins in Bordetella pertussis.

Authors:  Anissa M Cheung; Karen M Farizo; Drusilla L Burns
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

8.  Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine.

Authors:  S M Loosmore; G R Zealey; H A Boux; S A Cockle; K Radika; R E Fahim; G J Zobrist; R K Yacoob; P C Chong; F L Yao
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

9.  Bordetella pertussis risA, but not risS, is required for maximal expression of Bvg-repressed genes.

Authors:  Trevor H Stenson; Andrew G Allen; Jehan A Al-Meer; Duncan Maskell; Mark S Peppler
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

Review 10.  Progress towards recombinant anti-infective antibodies.

Authors:  Jennifer C Pai; Jamie N Sutherland; Jennifer A Maynard
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.